Galderma Investigational Site — Edina, Minnesota

Galderma Investigational Site is a clinical research site located in Edina, Minnesota, United States 55424-1200.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Galderma Investigational Site has participated in 2 clinical trials.

Therapeutic areas: Actinic Keratoses, Keratosis, Actinic.

Sponsors: Galderma R&D.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Edina

Browse all research sites in Minnesota · View every site in Edina

• Fairview-Southdale Hospital
• Twin Cities Orthopaedics, University of Minnesota Medical Center
• Fairview Hospital
• M Health Fairview Southdale Hospital
• University of Minnesota
• St. John's Hospital
• Southdale Cancer Care, University of Minnesota Medical Center- Edina ( Site 2016)
• Radiant Research
• Research Site
• Minnesota Oncology Edina
• GSK Investigational Site
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Galderma Investigational Site?

Galderma Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Galderma Investigational Site conducted?

Galderma Investigational Site has 2 clinical trials on record. Their work covers Actinic Keratoses, Keratosis, Actinic.

Is Galderma Investigational Site accredited by Crixeo Clinical Trials?

Galderma Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Galderma Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.